Cerebral Antibiotics Distribution After Acute Brain Injury
Information source: Poitiers University Hospital
Information obtained from ClinicalTrials.gov on February 07, 2013
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Bacterial Infection; Brain Injury
Intervention: cefotaxime (Drug); Metronidazole (Drug); Ciprofloxacin (Drug); Fosfocine (Drug)
Phase: Phase 1
Status: Recruiting
Sponsored by: Poitiers University Hospital Overall contact:
Claire DAHYOT, MD, Phone: 05 49 44 44 44, Ext: 41369, Email: c.dahyot-fizelier@chu-poitiers.fr
Summary
The aim of the study is to explore the distribution of antibiotics in the brain after an
acute brain injury because brain infections treatment is still an health care problem.
Clinical Details
Study design: N/A
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Acute brain injury
- Patient who receive an antibiotic for an infection or prophylaxy
- Glasgow coma score < 8
Exclusion Criteria:
- Age < 18 years old
- Pregnant woman
- HCV, HIV, HBV infection
Locations and Contacts
Claire DAHYOT, MD, Phone: 05 49 44 44 44, Ext: 41369, Email: c.dahyot-fizelier@chu-poitiers.fr
Poitiers University Hospital - 2 rue de la Milétrie - Réanimation chirugicale, Poitiers 86021, France; Recruiting
Claire DAHYOT, MD, Phone: 05 49 44 44 44, Ext: 41369, Email: c.dahyot-fizelier@chu-poitiers.fr
Additional Information
Last updated: January 29, 2010
|
